Coherent Market Insights

Flow Cytometry Market to Surpass US$ 12,532.8 Mn by 2030

Flow Cytometry Market to Surpass US$ 12,532.8 Mn by 2030 - Coherent Market Insights

Publish In: Nov 17, 2022

Global Flow Cytometry Market, by Technology (Cell Based, Bead Based), by Product Type (Analyzer, Sorter, Reagent & Consumables), by Application (Research, Clinical, Industrial), by End User (Hospitals, Clinical Testing Laboratories, Research Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 5,688.7 Million in 2022 and is expected to exhibit a CAGR of 10.4% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Increasing adoption of inorganic strategies such as product launch by key market players is expected to drive the global flow cytometry market over the forecast period. For instance, in September 2022, BD, a medical technology company, announced that they had launched a Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow that enables higher quality experiments with faster time to insight for scientists working across a range of disciplines including immunology, virology, oncology and infectious disease monitoring.

Global Flow Cytometry Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been significantly impacted by the COVID-19 pandemic.

Many patients with COVID-19 have severe respiratory infection requires hospitalization and mechanical ventilation and defining the immune responses during COVID-19 could help to identify therapeutics and effective vaccines. However, the COVID-19 pandemic had a positive impact on the global flow cytometry market. For instance, in July 2020, according to the data published in Journal ScienceDirect, immune parameters of COVID-19 patients can be identified by high-dimensional flow cytometry. As it analyze the data for B-cells and elucidate the immune response pattern for COVID-19 patients.

Global Flow Cytometry Market: Key Developments

For instance, in September 2020, Agilent Technologies, Inc., a life science company, announced that they had launched NovoCyte Penteon, a sensitive flow cytometer with five lasers and up to 30 fluorescence channels which provides excellent sensitivity, resolution, speed, and flexibility by enabling the measurement of cells, bacteria and even micro vesicles using lasers and have expanded capabilities of UV laser excitation that accommodate multicolor flow cytometry assays.

Browse 45 Market Data Tables and 35 Figures spread through 160 Pages and in-depth TOC on “Global Flow Cytometry Market”- Forecast to 2030, Global Flow Cytometry Market, by Technology (Cell Based, Bead Based), by Product Type (Analyzer, Sorter, Reagent & Consumables), by Application (Research, Clinical, Industrial), by End User (Hospitals, Clinical Testing Laboratories, Research Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/flow-cytometry-market-1152

For instance, in November 2021, MilliporeSigma, a subsidiary of Merck KGaA, announced that they had launched ColorWheel flow cytometry portfolio. The ColorWheel uses technology optimized for flow cytometry that allows users to select antibodies and dyes for assembly in any desired combination that results in an output of mix and match antibodies and dyes analogous to a primary conjugated antibody.

Key Takeaways of the Global Flow Cytometry Market:

  • The global flow cytometry market is expected to exhibit a CAGR of 10.4% during the forecast period due to the increasing manufacturing capabilities by the key players in the market over the forecast period. For instance, in October 2021, BD, a medical technology company, announced that they had launched second center of excellence in flow cytometry for clinical research in Vellore, India. This center of excellence will serve as the National Reference Center for clinical diagnostic applications, wherein physicians, hematologists, lab specialists from India will come together to discuss standardization and practices in clinical flow cytometry
  • Among product type, analyzer is estimated to hold a dominant position in the global flow cytometry market over the forecast period due to the increasing product launch by key market players. For instance, in June 2019, Sony Biotechnology Inc., a subsidiary of Sony Corporation, announced that they had launched ID7000 flagship spectral cell analyzer, a flow cytometer that provides streamlined multicolor cell analysis for more than 44 colors with spectral technology up to 7 lasers and 1886 detectors that helps to detect dim and rare cells from heterogeneous cells by expanding the boundaries of cell analysis.
  • Among regions, North America is estimated to account for the largest market share in the global flow cytometry market over the forecast period, owing to adoption of inorganic strategies such as collaboration by key market players in that region. For instance, in August 2022, BD, a medical technology company, Inc., announced that they had collaborated with Laboratory Corporation of America Holdings., a clinical laboratory company, to develop flow cytometry. This collaboration will create a framework to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) which is intended to match patients with life-changing treatments for cancer and other diseases
  • Major players operating in the global flow cytometry market include General Electric, BD, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., Laboratory Corporation of America Holdings., and MilliporeSigma

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports


Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail


Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Created billion dollars of revenue impact on thousands of clients

trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.